Artificial Intelligence

Tenaya Therapeutics unveils promising interim data for its ARVC gene therapy, TN-401, hinting at a potential cure and igniting investor interest.

Tenaya Therapeutics seeks fresh capital to advance its heart disease pipeline, but the offering's structure raises dilution questions for investors.

PG&E's new grid tech does more than keep lights on; it's a vital upgrade for healthcare resilience, wildfire prevention, and safety in a changing climate.

New journalism awards tackle AI's risks and Indigenous health gaps, revealing how media innovation aims to build a healthier, more equitable Canada.

A routine filing reveals a major strategic play. See how BridgeBio Oncology uses special equity grants to attract top minds in the fierce race for a cancer cure.

Argan's repeated dividend hikes and record backlog reflect deep confidence, positioning it to capitalize on surging demand for critical energy infrastructure.

As TD SYNNEX prepares its full-year report, the results will be a crucial test of its AI strategy and a key indicator for the entire IT ecosystem.

A new partnership between a tech startup and an energy giant aims to give a digital identity to the unseen world of drilling, empowering humans with data.

A major European bank deepens its pact with HUB Cyber Security. We explore why this signals a critical shift in finance, regulation, and cyber defense.

With $150M from Crayhill Capital, Rostrum Pacific isn't just buying music history—it's building an integrated ecosystem to redefine its future.

As the AI skills gap widens, a new framework aims to move companies from pilot purgatory to true adoption by training everyone, not just tech experts.

GWI's new AI award signals a major shift. Discover how AI is reshaping the water sector and which companies are poised to lead this tech-driven transformation.

Augustus Sinclair’s Eon Prime unveils a new global identity, but is it selling a product, a philosophy, or the very blueprint for future wealth?

Fivetran's new Gartner status reveals a deeper industry shift: the race to build the unified data plumbing that will determine if we can trust AI.

Beyond logistics, new AI-powered systems are redefining trust and efficiency in drug development. See how one company is setting a new human-centered standard.

A $2.4B deal for Alphawave IP and a revealing investor filing pull back the curtain on the high-stakes race to build the infrastructure for an AI world.

Recent CPSC warnings reveal deadly products on the market. As regulators struggle with e-commerce, can AI become the tool we need to stop them?

Recent product recalls reveal deep flaws in our safety systems. What can this teach us about regulating the complex world of medical AI before it's too late?

Lucid Software’s ‘Awardable’ status on a key DoD marketplace signals a shift in how national security projects are planned, secured, and executed.

A major hedge fund's move in a $2.4B semiconductor deal reveals a critical truth: the future of precision medicine is built on high-speed data infrastructure.